Restoring cellular memory blocks cancer cells from adapting to escape treatment. Northwestern University biomedical engineers ...

University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than ...

A new formulation of the drug paclitaxel may help overcome some common limitations of chemotherapy drugs, setting the stage ...

The first trial of adjuvant platinum-based chemotherapy plus paclitaxel in patients with high-risk penile cancer provided some insights.

Treatment with a paclitaxel-coated balloon led to better outcomes in patients with multilayer in-stent restenosis compared with conventional balloon angioplasty.

A small percentage of species protected by the law have ever recovered, but an even smaller fraction have gone extinct. With ...

An artificial intelligence-informed blood test achieved 90% accuracy for diagnosing ovarian cancer, even at the earliest ...

Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the most promising future stocks according to Wall Street analysts.

Novocure (NASDAQ: NVCR) today announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fields (TTFields) therapy for the ...

The PANOVA-3 trial “establishes tumor treating fields with gemcitabine/nab-paclitaxel as a potential new standard treatment paradigm for unresectable, locally advanced pancreatic cancer,” said Vincent ...